Arcyriaflavin A, a cyclin D1/CDK4 inhibitor, suppresses tumor growth, migration, and invasion of metastatic melanoma cells

Abstract Background Despite advancements in targeted therapy and immunotherapy, cutaneous melanoma continues to have a high mortality rate and poor prognosis, with therapies having limited efficacy in advanced melanoma. Therefore, it is crucial to develop novel therapeutics with proven clinical pote...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Dokyeong Kim, Junseong Park, Yoon-Seob Kim, Okcho Na, Minyoung Park, Songzi Zhang, Sumin Cho, Yeun-Jun Chung
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-02-01
סדרה:	Cancer Cell International
נושאים:	Anti-cancer therapy Arcyriaflavin A Cyclin D1 CDK4 Metastatic melanoma
גישה מקוונת:	https://doi.org/10.1186/s12935-025-03675-4
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!